Name: | Description: | Size: | Format: | |
---|---|---|---|---|
743.89 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
A regurgitação mitral Ć© atualmente a anormalidade valvular mais frequente a nĆvel mundial, podendo ser aguda ou crónica. A presente monografia tem como objetivo fazer uma revisĆ£o da regurgitação mitral crónica, focando-se essencialmente no seu tratamento.
A regurgitação mitral crónica, se nĆ£o tratada, contribui para o aparecimento de disfunção sistólica e diastólica que por fim leva Ć insuficiĆŖncia cardĆaca.
A principal classificação envolve a divisão em regurgitação mitral primÔria/orgânica e secundÔria/funcional.
A cirurgia Ć© o gold standard do tratamento da regurgitação mitral primĆ”ria, mas apresenta resultados equĆvocos na regurgitação mitral funcional. Nestes, a terapĆŖutica baseia-se essencialmente no tratamento mĆ©dico da insuficiĆŖncia cardĆaca e na terapia de ressincronização cardĆaca, ficando a cirurgia reservada para Ćŗltimo caso.
Contudo, muitos pacientes não são candidatos adequados à cirurgia. Um em cada dois pacientes não pode ser operado em consequência do risco cirúrgico muito alto ou até mesmo proibitivo.
O desenvolvimento recente de técnicas de reparação minimamente invasivas por via percutânea veio criar uma opção adicional para estes pacientes.
Mitral regurgitation is currently the most frequent valvular abnormality worldwide and may be acute or chronic. This monograph aims at reviewing chronic mitral regurgitation, focusing essentially on its treatment. Chronic mitral regurgitation, if left untreated, contributes to the development of systolic and diastolic dysfunction that ultimately leads to heart failure. The main classification involves the division into primary/organic and secondary/functional mitral regurgitation. Surgery is the gold standard for the treatment of primary mitral regurgitation, but presents equivocal results in functional mitral regurgitation. In these, the therapy is based essentially on the medical treatment of heart failure and cardiac resynchronization therapy, leaving the surgery reserved as a last resort. However, many patients are not suitable candidates for surgery. One in two patients cannot be operated as a result of very high or even prohibitive surgical risk. The recent development of minimally invasive percutaneous repair techniques has created an additional option for these patients.
Mitral regurgitation is currently the most frequent valvular abnormality worldwide and may be acute or chronic. This monograph aims at reviewing chronic mitral regurgitation, focusing essentially on its treatment. Chronic mitral regurgitation, if left untreated, contributes to the development of systolic and diastolic dysfunction that ultimately leads to heart failure. The main classification involves the division into primary/organic and secondary/functional mitral regurgitation. Surgery is the gold standard for the treatment of primary mitral regurgitation, but presents equivocal results in functional mitral regurgitation. In these, the therapy is based essentially on the medical treatment of heart failure and cardiac resynchronization therapy, leaving the surgery reserved as a last resort. However, many patients are not suitable candidates for surgery. One in two patients cannot be operated as a result of very high or even prohibitive surgical risk. The recent development of minimally invasive percutaneous repair techniques has created an additional option for these patients.
Description
Keywords
Mitraclip Regurgitação Mitral Tratamento da Regurgitação Mitral